You have free access to this content

Hepatology

Cover image for Vol. 57 Issue 6

June 2013

Volume 57, Issue 6

Pages 2097–2554

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Hepatopulmonary syndrome and liver transplantation: Who, when, and where? (pages 2097–2099)

      Rajasekhar Tanikella and Michael B. Fallon

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26367

    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Association of tattooing and hepatitis C virus infection: A multicenter case-control study (pages 2117–2123)

      Kerrilynn Carney, Sameer Dhalla, Ayse Aytaman, Craig T. Tenner and Fritz Francois

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26245

    2. You have free access to this content
      Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection (pages 2124–2134)

      Jason Grebely, Jordan J. Feld, Tanya Applegate, Gail V. Matthews, Margaret Hellard, Alana Sherker, Kathy Petoumenos, Geng Zang, Ineke Shaw, Barbara Yeung, Jacob George, Suzy Teutsch, John M. Kaldor, Vera Cherepanov, Julie Bruneau, Naglaa H. Shoukry, Andrew R. Lloyd and Gregory J. Dore

      Version of Record online: 8 MAY 2013 | DOI: 10.1002/hep.26263

    3. You have free access to this content
      Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up (pages 2135–2142)

      Ming-Lung Yu, Chuan-Mo Lee, Chi-Ling Chen, Wan-Long Chuang, Sheng-Nan Lu, Chen-Hua Liu, Shun-Sheng Wu, Li-Ying Liao, Hsing-Tao Kuo, You-Chen Chao, Shui-Yi Tung, Sien-Sing Yang, Jia-Horng Kao, Wei-Wen Su, Chih-Lin Lin, Hung-Chih Yang, Pei-Jer Chen, Ding-Shinn Chen, Chun-Jen Liu and for the Taiwan Liver-Net Consortium

      Version of Record online: 26 APR 2013 | DOI: 10.1002/hep.26266

    4. You have free access to this content
      Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial (pages 2143–2154)

      Mark S. Sulkowski, Tarik Asselah, Jacob Lalezari, Peter Ferenci, Hugo Fainboim, Barbara Leggett, Fernando Bessone, Stefan Mauss, Jeong Heo, Yakov Datsenko, Jerry O. Stern, George Kukolj, Joseph Scherer, Gerhard Nehmiz, Gerhard G. Steinmann and Wulf O. Böcher

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26276

    5. You have free access to this content
      Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial (pages 2155–2163)

      Mark S. Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki, Tarik Asselah, Jean-Michel Pawlotsky, Stephen D. Shafran, Stanislas Pol, Stefan Mauss, Dominique Larrey, Yakov Datsenko, Jerry O. Stern, George Kukolj, Joseph Scherer, Gerhard Nehmiz, Gerhard G. Steinmann and Wulf O. Böcher

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26386

    6. You have full text access to this OnlineOpen article
      Chronic hepatitis C virus (HCV) disease burden and cost in the United States (pages 2164–2170)

      Homie Razavi, Antoine C. ElKhoury, Elamin Elbasha, Chris Estes, Ken Pasini, Thierry Poynard and Ritesh Kumar

      Version of Record online: 6 MAY 2013 | DOI: 10.1002/hep.26218

  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate (pages 2171–2179)

      George A. Diaz, Lauren S. Krivitzky, Masoud Mokhtarani, William Rhead, James Bartley, Annette Feigenbaum, Nicola Longo, William Berquist, Susan A. Berry, Renata Gallagher, Uta Lichter-Konecki, Dennis Bartholomew, Cary O. Harding, Stephen Cederbaum, Shawn E. McCandless, Wendy Smith, Gerald Vockley, Stephen A. Bart, Mark S. Korson, David Kronn, Roberto Zori, J. Lawrence Merritt II, Sandesh C.S. Nagamani, Joseph Mauney, Cynthia LeMons, Klara Dickinson, Tristen L. Moors, Dion F. Coakley, Bruce F. Scharschmidt and Brendan Lee

      Version of Record online: 3 JAN 2013 | DOI: 10.1002/hep.26058

    2. You have free access to this content
      Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause? (pages 2180–2188)

      David van der Poorten, Caroline F. Samer, Mehdi Ramezani-Moghadam, Sally Coulter, Marina Kacevska, Dennis Schrijnders, Lindsay E. Wu, Duncan McLeod, Elisabetta Bugianesi, Mina Komuta, Tania Roskams, Christopher Liddle, Lionel Hebbard and Jacob George

      Version of Record online: 18 JAN 2013 | DOI: 10.1002/hep.26072

    3. You have free access to this content
      Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents (pages 2189–2201)

      Maximilian Hatting, Gang Zhao, Fabienne Schumacher, Gernot Sellge, Malika Al Masaoudi, Nikolaus Gaβler, Mark Boekschoten, Michael Müller, Christian Liedtke, Francisco Javier Cubero and Christian Trautwein

      Version of Record online: 6 MAY 2013 | DOI: 10.1002/hep.26271

    4. You have free access to this content
      Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease (pages 2202–2212)

      Anping Chen, Youcai Tang, Victoria Davis, Fong-Fu Hsu, Susan M. Kennedy, Haowei Song, John Turk, Elizabeth M. Brunt, Elizabeth P. Newberry and Nicholas O. Davidson

      Version of Record online: 15 MAY 2013 | DOI: 10.1002/hep.26318

    5. You have free access to this content
      Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect (pages 2213–2223)

      R. Scott Rector, E. Matthew Morris, Suzanne Ridenhour, Grace M. Meers, Fong-Fu Hsu, John Turk and Jamal A. Ibdah

      Version of Record online: 26 APR 2013 | DOI: 10.1002/hep.26285

  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma (pages 2224–2234)

      Wolfgang Sieghart, Matthias Pinter, Florian Hucke, Ivo Graziadei, Maximilian Schöniger-Hekele, Christian Müller, Wolfgang Vogel, Michael Trauner and Markus Peck-Radosavljevic

      Version of Record online: 18 JAN 2013 | DOI: 10.1002/hep.26057

    2. You have free access to this content
      αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma (pages 2235–2247)

      Xiao-Yong Huang, Ai-Wu Ke, Guo-Ming Shi, Xin Zhang, Chi Zhang, Ying-Hong Shi, Xiao-Ying Wang, Zhen-Bin Ding, Yong-Sheng Xiao, Jun Yan, Shuang-Jian Qiu, Jia Fan and Jian Zhou

      Version of Record online: 14 MAY 2013 | DOI: 10.1002/hep.26255

    3. You have free access to this content
    4. You have free access to this content
      The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma (pages 2261–2273)

      Wolfgang Sieghart, Florian Hucke, Matthias Pinter, Ivo Graziadei, Wolfgang Vogel, Christian Müller, Harald Heinzl, Michael Trauner and Markus Peck-Radosavljevic

      Version of Record online: 3 MAY 2013 | DOI: 10.1002/hep.26256

    5. You have free access to this content
      Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: Role of the S100A4-miR155-SOCS1-MMP9 axis (pages 2274–2286)

      Xin-Long Yan, Ya-Li Jia, Lin Chen, Quan Zeng, Jun-Nian Zhou, Chun-Jiang Fu, Hai-Xu Chen, Hong-Feng Yuan, Zhi-Wei Li, Lei Shi, Ying-Chen Xu, Jing-Xue Wang, Xiao-Mei Zhang, Li-Juan He, Chao Zhai, Wen Yue and Xue-Tao Pei

      Version of Record online: 1 MAY 2013 | DOI: 10.1002/hep.26257

    6. You have free access to this content
      SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling (pages 2287–2298)

      Juan Chen, Anthony W.H. Chan, Ka-Fai To, Weixian Chen, Zhenzhen Zhang, Jihua Ren, Chunli Song, Yue-Sun Cheung, Paul B.S. Lai, Suk-Hang Cheng, Margaret H.L. Ng, Ailong Huang and Ben C.B. Ko

      Version of Record online: 26 APR 2013 | DOI: 10.1002/hep.26278

    7. You have free access to this content
      MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer (pages 2299–2313)

      Hui Peng, Lily Dara, Tony W.H. Li, Yuhua Zheng, Heping Yang, Maria Lauda Tomasi, Ivan Tomasi, Pasquale Giordano, Jose M. Mato and Shelly C. Lu

      Version of Record online: 14 MAY 2013 | DOI: 10.1002/hep.26258

    8. You have free access to this content
      Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis (pages 2314–2325)

      Toshiya Kamiyama, Hideki Yokoo, Jun-Ichi Furukawa, Masaki Kurogochi, Tomoaki Togashi, Nobuaki Miura, Kazuaki Nakanishi, Hirofumi Kamachi, Tatsuhiko Kakisaka, Yosuke Tsuruga, Masato Fujiyoshi, Akinobu Taketomi, Shin-Ichiro Nishimura and Satoru Todo

      Version of Record online: 26 APR 2013 | DOI: 10.1002/hep.26262

    9. You have free access to this content
      BTB/POZ domain-containing protein 7: Epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma (pages 2326–2337)

      Yi-Ming Tao, Jin-Lin Huang, Shan Zeng, Sai Zhang, Xue-Gong Fan, Zhi-Ming Wang, Hui-Xiang Yang, Xiao-Hua Yuan, Pu Wang, Fan Wu, Jia Luo, De-Yu Zeng and Hong Shen

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26268

    10. You have free access to this content
      Soluble receptor for advanced glycation end products and risk of liver cancer (pages 2338–2345)

      Kristin A. Moy, Li Jiao, Neal D. Freedman, Stephanie J. Weinstein, Rashmi Sinha, Jarmo Virtamo, Demetrius Albanes and Rachael Z. Stolzenberg-Solomon

      Version of Record online: 14 MAY 2013 | DOI: 10.1002/hep.26264

    11. You have free access to this content
      Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or delayed? (pages 2346–2357)

      Zi Yin, Chao Liu, Yajin Chen, Yu Bai, Changzhen Shang, Rongyan Yin, Dong Yin and Jie Wang

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26283

    12. You have free access to this content
      Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells (pages 2358–2368)

      Martin Franz Sprinzl, Florian Reisinger, Andreas Puschnik, Marc Ringelhan, Kerstin Ackermann, Daniel Hartmann, Matthias Schiemann, Arndt Weinmann, Peter Robert Galle, Marcus Schuchmann, Helmut Friess, Gerd Otto, Mathias Heikenwalder and Ulrike Protzer

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26328

    13. You have free access to this content
      Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma (pages 2369–2377)

      Jiaxin Xie, Yuwei Zhang, Qi Zhang, Yifang Han, Jianhua Yin, Rui Pu, Qiuxia Shen, Wei Lu, Yan Du, Jun Zhao, Xue Han, Hongwei Zhang and Guangwen Cao

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26303

    14. You have free access to this content
      A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis (pages 2378–2389)

      Han Han, Dan Sun, Wenjuan Li, Hongxing Shen, Yahui Zhu, Chen Li, Yuxing Chen, Longfeng Lu, Wenhua Li, Jinxiang Zhang, Yuan Tian and Youjun Li

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26302

  5. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis (pages 2390–2398)

      Lucas J. Maillette de Buy Wenniger, Marieke E. Doorenspleet, Paul L. Klarenbeek, Joanne Verheij, Frank Baas, Ronald P. Oude Elferink, Paul P. Tak, Niek de Vries and Ulrich Beuers

      Version of Record online: 8 MAY 2013 | DOI: 10.1002/hep.26232

    2. You have free access to this content
      Predictors of poor outcome in patients w ith autoimmune hepatitis: A population-based study (pages 2399–2406)

      Jing Hieng Ngu, Richard Blair Gearry, Chris Miles Frampton and Catherine A.M. Stedman

      Version of Record online: 1 MAY 2013 | DOI: 10.1002/hep.26290

    3. You have free access to this content
      Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus (pages 2407–2417)

      Oliver von Kampen, Stephan Buch, Michael Nothnagel, Lorena Azocar, Hector Molina, Mario Brosch, Wiebke Erhart, Witigo von Schönfels, Jan Egberts, Marcus Seeger, Alexander Arlt, Tobias Balschun, Andre Franke, Markus M. Lerch, Julia Mayerle, Wolfgang Kratzer, Bernhard O. Boehm, Klaus Huse, Bodo Schniewind, Katharina Tiemann, Zhao-Yan Jiang, Tian-Quan Han, Balraj Mittal, Anshika Srivastava, Mogens Fenger, Torben Jørgensen, Ramin Schirin-Sokhan, Anke Tönjes, Henning Wittenburg, Michael Stumvoll, Holger Kalthoff, Frank Lammert, Jürgen Tepel, Klaus Puschel, Thomas Becker, Stefan Schreiber, Matthias Platzer, Henry Völzke, Michael Krawczak, Juan Francisco Miquel, Clemens Schafmayer and Jochen Hampe

      Version of Record online: 25 JAN 2013 | DOI: 10.1002/hep.26009

    4. You have free access to this content
      Adult sea lamprey tolerates biliary atresia by altering bile salt composition and renal excretion (pages 2418–2426)

      Shi-Ying Cai, Daniël A. Lionarons, Lee Hagey, Carol J. Soroka, Albert Mennone and James L. Boyer

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26161

  6. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era (pages 2427–2435)

      Vivek N. Iyer, Karen L. Swanson, Rodrigo Cartin-Ceba, Ross A. Dierkhising, Charles B. Rosen, Julie K. Heimbach, Russell H. Wiesner and Michael J. Krowka

      Version of Record online: 15 FEB 2013 | DOI: 10.1002/hep.26070

    2. You have free access to this content
  7. Liver Failure/ Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy (pages 2448–2457)

      Wim Laleman, Macarena Simon-Talero, Geert Maleux, Mercedes Perez, Koen Ameloot, German Soriano, Jordi Villalba, Juan-Carlos Garcia-Pagan, Marta Barrufet, Rajiv Jalan, Jocelyn Brookes, Evangelos Thalassinos, Andrew K. Burroughs, Juan Cordoba, Frederik Nevens and on behalf of the EASL-CLIF-Consortium

      Version of Record online: 1 MAY 2013 | DOI: 10.1002/hep.26314

  8. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells (pages 2458–2468)

      Su Mi Choi, Yonghak Kim, Joong Sup Shim, Joon Tae Park, Rui-Hong Wang, Steven D. Leach, Jun O. Liu, Chuxia Deng, Zhaohui Ye and Yoon-Young Jang

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26237

  9. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1 (pages 2469–2479)

      Petia Jeliazkova, Simone Jörs, Marcel Lee, Ursula Zimber-Strobl, Jorge Ferrer, Roland M. Schmid, Jens T. Siveke and Fabian Geisler

      Version of Record online: 17 APR 2013 | DOI: 10.1002/hep.26254

    2. You have free access to this content
      Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents (pages 2480–2490)

      Chad Walesky, Genea Edwards, Prachi Borude, Sumedha Gunewardena, Maura O'Neil, Byunggil Yoo and Udayan Apte

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26251

    3. You have free access to this content
      Genome-wide microRNA and messenger RNA profiling in rodent liver development implicates mir302b and mir20a in repressing transforming growth factor-beta signaling (pages 2491–2501)

      Wei Wei, Juan Hou, Olivia Alder, Xin Ye, Sam Lee, Rebecca Cullum, Andy Chu, Yongjun Zhao, Stephanie M. Warner, Darryl A. Knight, Decheng Yang, Steven J.M. Jones, Marco A. Marra and Pamela A. Hoodless

      Version of Record online: 26 APR 2013 | DOI: 10.1002/hep.26252

    4. You have free access to this content
      Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice (pages 2502–2513)

      Kei Kiyohashi, Sei Kakinuma, Akihide Kamiya, Naoya Sakamoto, Sayuri Nitta, Hideto Yamanaka, Kouhei Yoshino, Junko Fujiki, Miyako Murakawa, Akiko Kusano-Kitazume, Hiromichi Shimizu, Ryuichi Okamoto, Seishin Azuma, Mina Nakagawa, Yasuhiro Asahina, Naoki Tanimizu, Akira Kikuchi, Hiromitsu Nakauchi and Mamoru Watanabe

      Version of Record online: 14 MAY 2013 | DOI: 10.1002/hep.26293

    5. You have free access to this content
  10. Reviews

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Dietary fructose in nonalcoholic fatty liver disease (pages 2525–2531)

      Miriam B. Vos and Joel E. Lavine

      Version of Record online: 1 MAY 2013 | DOI: 10.1002/hep.26299

  11. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Cracking the ENCODE: From transcription to therapeutics (pages 2532–2535)

      Gautam Mehta, Rajiv Jalan and Rajeshwar P Mookerjee

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26449

    2. You have free access to this content
  12. Clinical Observations in Hepatology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Cholestasis in a patient with gallstones and a normal gamma-glutamyl transferase (pages 2539–2541)

      Sheida Moghadamrad, Matteo Montani, Rosemarie Weimann and Andrea De Gottardi

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26344

  13. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Long-lived intragraft donor leukocytes or relocated donor hematopoietic stem/progenitor cells can cause long-term hematopoietic chimerism after liver transplantation (page 2542)

      Xiaolei Shi M.D., Viviana Moroso Ph.D., Herold J. Metselaar M.D., Ph.D. and Jaap Kwekkeboom Ph.D.

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26118

    2. You have free access to this content
    3. You have free access to this content
      Selenium levels in patients with hepatitis C virus-related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: A pilot study (pages 2543–2544)

      Dominik Bettinger, Michael Schultheiss, Nadine Hennecke, Elisabeth Panther, Eva Knüppel, Hubert E. Blum, Robert Thimme and Hans Christian Spangenberg

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26142

    4. You have free access to this content
    5. You have free access to this content
      Reply (page 2545)

      George N. Ioannou, Christopher L. Bryson, Noel S. Weiss, John D. Scott and Edward J. Boyko

      Version of Record online: 14 MAR 2013 | DOI: 10.1002/hep.26171

    6. You have free access to this content
    7. You have free access to this content
      Reply: (page 2547)

      Gyongyi Szabo and Shashi Bala

      Version of Record online: 28 MAY 2013 | DOI: 10.1002/hep.26111

    8. You have free access to this content
      Overestimation of hematopoietic stem cell frequencies in human liver grafts (pages 2547–2549)

      Sean R.R. Hall, Alexander Pedroza-Gonzalez, Qiuwei Pan, Hugo W. Tilanus, Jeroen de Jonge, Gerard Wagemaker and Luc J.W. van der Laan

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26119

  14. Obituary

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
  15. Correction

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Failure/ Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Obituary
    16. Correction
    1. You have free access to this content
      Correction (page 2553)

      Version of Record online: 14 MAY 2013 | DOI: 10.1002/hep.26291

    2. You have free access to this content
      Correction (page 2554)

      Version of Record online: 12 JUN 2013 | DOI: 10.1002/hep.26479

SEARCH

SEARCH BY CITATION